AFIRE - Rivaroxaban monotherapy versus combination therapy in patients with atrial fibrillation and stable coronary artery disease
2 September 2019 (11:18 - 11:30)
Organised by:
About the speaker
Tohoku University, Sendai (Japan)
14 More presentations in this session
Professor B. Ference (Cambridge, GB)
Professor J. Hopewell (Oxford, GB)
Access the full session
The Event
ESC Congress 2019
2 September 2019
11:18 CET
